BFEC
CDNA icon

Benjamin F. Edwards & Company’s CareDx CDNA Stock Holding History

Benjamin F. Edwards & Company’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-787
Closed -$28K – 1671
2020
Q2 		$28K Buy
+787
New +$22.4K ﹤0.01% 1019
2020
Q1 		– Sell
-92
Closed -$2K – 1725
2019
Q4 		$2K Buy
+92
New +$2.11K ﹤0.01% 1758

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Benjamin F. Edwards & Company's CDNA Position: Q3 2020 in Review

Benjamin F. Edwards & Company sold out of CareDx (CDNA) in Q3 2020, closing a stake of 787 shares — an estimated $28K sold.

Benjamin F. Edwards & Company first reported a position in CDNA in Q4 2019 and held it in 2 quarters. The position peaked at $28K in Q2 2020. 197 funds tracked by Wall St. Rank hold CDNA as of Q3 2020.

  • Benjamin F. Edwards & Company reported no remaining CareDx position as of Q3 2020 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 787 CareDx shares in Q3 2020, an estimated $28K.
  • Benjamin F. Edwards & Company first reported a position in CareDx in Q4 2019 and held it in 2 quarters.
  • Benjamin F. Edwards & Company's CareDx position peaked at $28K in Q2 2020.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q3 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2020, filed 13 Nov 2020.